Iris Raises $14M for Advanced Contact Lens Manufacturing

Xiamen-based Aireesee, a significant player in the contact lens research, development, and manufacturing sector, has successfully closed a Series B+ funding round, securing over 100 million yuan (approximately $14 million USD). This substantial capital injection was spearheaded by Qianqi Capital, with Yikai Capital providing crucial financial advisory services throughout the transaction.

Aireesee distinguishes itself through its state-of-the-art, fully automated manufacturing facilities, adhering to Industry 4.0 principles. The company operates as a contract development and manufacturing organization (CDMO/ODM), empowering branded contact lens companies with advanced production capabilities. Notably, Aireesee claims to be the first domestic Chinese manufacturer in its field to achieve independent innovation across core material science, process engineering, and production equipment design, meeting or surpassing global benchmarks set by leading international firms from North America, Europe, Japan, South Korea, and Taiwan.

The company's technological prowess is evident in its development of high-performance silicon hydrogel lenses boasting an oxygen transmissibility (Dk/t) exceeding 160. Furthermore, Aireesee is actively engaged in creating soft defocus lenses designed for myopia management in younger demographics. A key innovation is its proprietary Oxi-free technology, developed in collaboration with esteemed institutions like Moody, Tsinghua University, and Zhejiang Second Hospital, targeting the treatment of dry eye conditions. Aireesee's commitment to intellectual property is underscored by its portfolio of 18 patents covering critical areas such as equipment automation, manufacturing workflows, and intelligent control systems.

The contact lens market, a segment within the broader global vision care industry valued at over $10 billion USD and projected to grow at a CAGR of approximately 5-6%, is increasingly driven by technological advancements and demand for specialized products. Aireesee's focus on high-performance materials and therapeutic solutions positions it to capture a significant share of this expanding market, particularly as consumer awareness regarding eye health and myopia prevention rises.

This latest funding will be strategically deployed to enhance Aireesee's production capacity, accelerate research into next-generation contact lens materials, and bolster its manufacturing infrastructure to meet escalating demand from both domestic and international clients. The company has already established relationships with prominent brands including Moody, Shike Group, Lemonade, Labaishi, and Sweet Color, demonstrating its market traction and the trust placed in its manufacturing expertise.

Aireesee's core team comprises seasoned professionals, including individuals with international academic backgrounds from prestigious institutions such as Harvard, Stanford, Berkeley, and Carnegie Mellon, alongside extensive industry experience from global technology leaders like Intel, Samsung, and Huawei. This blend of cutting-edge research and deep operational expertise provides a strong foundation for the company's ambitious growth plans in the competitive global contact lens arena.